Detalhe da pesquisa
1.
Immune evasion before tumour invasion in early lung squamous carcinogenesis.
Nature
; 571(7766): 570-575, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31243362
2.
Biomarkers and immunotherapy: where are we?
Curr Opin Oncol
; 34(5): 579-586, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35943441
3.
Targeting CTLA-4 in cancer: Is it the ideal companion for PD-1 blockade immunotherapy combinations?
Int J Cancer
; 149(1): 31-41, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33252786
4.
PD-1hiCXCR5-CD4+ TFH Cells Play Defense in Cancer and Offense in Arthritis.
Trends Immunol
; 38(12): 875-878, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29111220
5.
The impact of tumor cell metabolism on T cell-mediated immune responses and immuno-metabolic biomarkers in cancer.
Semin Cancer Biol
; 52(Pt 2): 66-74, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29574171
6.
Age-related changes in the BACH2 and PRDM1 genes in lymphocytes from healthy donors and chronic lymphocytic leukemia patients.
BMC Cancer
; 19(1): 81, 2019 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30654767
7.
FOXP1 is a regulator of quiescence in healthy human CD4+ T cells and is constitutively repressed in T cells from patients with lymphoproliferative disorders.
Eur J Immunol
; 47(1): 168-179, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27861791
8.
Inflammatory Stroma of Lymphoepithelioma-like Carcinoma of the Cervix: Immunohistochemical Study of 3 Cases and Review of the Literature.
Int J Gynecol Pathol
; 37(5): 482-487, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28985196
9.
Reliability of tumor-infiltrating lymphocyte and tertiary lymphoid structure assessment in human breast cancer.
Mod Pathol
; 30(9): 1204-1212, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28621322
10.
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group.
Mod Pathol
; 29(10): 1155-64, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27363491
11.
Circulating (CD3(-)CD19(+)CD20(-)IgD(-)CD27(high)CD38(high)) Plasmablasts: A Promising Cellular Biomarker for Immune Activity for Anti-PLA2R1 Related Membranous Nephropathy?
Mediators Inflamm
; 2016: 7651024, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27493452
12.
Intratumoral administration of the immunologic adjuvant AS01B in combination with autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells plus ipilimumab and intravenous nivolumab in patients with refractory advanced melanoma.
J Immunother Cancer
; 12(1)2024 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38212127
13.
Concomitant Expression of CD39, CD69, and CD103 Identifies Antitumor CD8+ T cells in Breast Cancer Implications for Adoptive Cell Therapy.
Curr Pharm Biotechnol
; 2023 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37680154
14.
Immune response to anti-SARS-CoV-2 prime-vaccination in patients with cancer: a systematic review and meta-analysis.
J Cancer Res Clin Oncol
; 149(7): 3075-3080, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35867203
15.
Primary adrenal insufficiency induced by immune checkpoint inhibitors: biological, clinical, and radiological aspects.
Semin Oncol
; 50(6): 144-148, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38151399
16.
Characterization of Immunoactive and Immunotolerant CD4+ T Cells in Breast Cancer by Measuring Activity of Signaling Pathways That Determine Immune Cell Function.
Cancers (Basel)
; 14(3)2022 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35158758
17.
Thromboembolism and Immune Checkpoint Blockade in Cancer Patients: An Old Foe for New Research.
Target Oncol
; 17(5): 497-505, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36102923
18.
A Rare Case of Hepatic Vanishing Bile Duct Syndrome Occurring after Combination Therapy with Nivolumab and Cabozantinib in a Patient with Renal Carcinoma.
Diagnostics (Basel)
; 12(2)2022 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35204627
19.
Low-Dose Nivolumab with or without Ipilimumab as Adjuvant Therapy Following the Resection of Melanoma Metastases: A Sequential Dual Cohort Phase II Clinical Trial.
Cancers (Basel)
; 14(3)2022 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35158952
20.
Molecular profiling of CD3-CD4+ T cells from patients with the lymphocytic variant of hypereosinophilic syndrome reveals targeting of growth control pathways.
Blood
; 114(14): 2969-83, 2009 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19608752